Leonid Timashev
Stock Analyst at RBC Capital
(2.33)
# 2,646
Out of 4,969 analysts
106
Total ratings
46.88%
Success rate
-2.54%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $145 → $151 | $131.79 | +14.58% | 1 | Aug 28, 2025 | |
| XNCR Xencor | Maintains: Outperform | $32 → $15 | $8.33 | +80.07% | 1 | Aug 21, 2025 | |
| INSM Insmed | Maintains: Outperform | $120 → $138 | $143.50 | -3.83% | 5 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Outperform | $75 → $77 | $35.95 | +114.19% | 13 | Aug 12, 2025 | |
| VSTM Verastem | Maintains: Outperform | $12 → $13 | $9.50 | +36.84% | 2 | Aug 8, 2025 | |
| NUVB Nuvation Bio | Maintains: Outperform | $6 → $7 | $3.15 | +122.22% | 2 | Aug 8, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Outperform | $48 → $49 | $14.64 | +234.81% | 14 | Aug 8, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $38 → $39 | $24.88 | +56.75% | 7 | Aug 7, 2025 | |
| ONC BeOne Medicines AG | Maintains: Outperform | $349 → $364 | $336.26 | +8.25% | 3 | Aug 7, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Outperform | $184 → $189 | $122.00 | +54.92% | 13 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $40 → $42 | $30.00 | +40.00% | 3 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $50 → $45 | $36.96 | +21.75% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $25 | $7.09 | +252.86% | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $53 | $28.67 | +84.86% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $57 → $30 | $25.76 | +16.46% | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 → $17 | $13.70 | +24.09% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $5 | $3.29 | +51.98% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $3.38 | +373.37% | 1 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $54 → $21 | $16.21 | +29.55% | 12 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $80 | $49.99 | +60.03% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $1.47 | +444.22% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.54 | +94.81% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $86.96 | -19.50% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $18 | $4.71 | +282.17% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $5.97 | -33.00% | 8 | Aug 6, 2024 |
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Outperform
Price Target: $145 → $151
Current: $131.79
Upside: +14.58%
Xencor
Aug 21, 2025
Maintains: Outperform
Price Target: $32 → $15
Current: $8.33
Upside: +80.07%
Insmed
Aug 13, 2025
Maintains: Outperform
Price Target: $120 → $138
Current: $143.50
Upside: -3.83%
Legend Biotech
Aug 12, 2025
Maintains: Outperform
Price Target: $75 → $77
Current: $35.95
Upside: +114.19%
Verastem
Aug 8, 2025
Maintains: Outperform
Price Target: $12 → $13
Current: $9.50
Upside: +36.84%
Nuvation Bio
Aug 8, 2025
Maintains: Outperform
Price Target: $6 → $7
Current: $3.15
Upside: +122.22%
Edgewise Therapeutics
Aug 8, 2025
Maintains: Outperform
Price Target: $48 → $49
Current: $14.64
Upside: +234.81%
NewAmsterdam Pharma Company
Aug 7, 2025
Maintains: Outperform
Price Target: $38 → $39
Current: $24.88
Upside: +56.75%
BeOne Medicines AG
Aug 7, 2025
Maintains: Outperform
Price Target: $349 → $364
Current: $336.26
Upside: +8.25%
Axsome Therapeutics
Aug 5, 2025
Maintains: Outperform
Price Target: $184 → $189
Current: $122.00
Upside: +54.92%
Jul 30, 2025
Maintains: Sector Perform
Price Target: $40 → $42
Current: $30.00
Upside: +40.00%
Jul 29, 2025
Maintains: Sector Perform
Price Target: $50 → $45
Current: $36.96
Upside: +21.75%
Jul 17, 2025
Maintains: Outperform
Price Target: $32 → $25
Current: $7.09
Upside: +252.86%
Jul 16, 2025
Maintains: Outperform
Price Target: $68 → $53
Current: $28.67
Upside: +84.86%
Jul 9, 2025
Maintains: Outperform
Price Target: $57 → $30
Current: $25.76
Upside: +16.46%
Jun 20, 2025
Reiterates: Outperform
Price Target: $13 → $17
Current: $13.70
Upside: +24.09%
Jun 20, 2025
Maintains: Outperform
Price Target: $8 → $5
Current: $3.29
Upside: +51.98%
Jun 3, 2025
Maintains: Outperform
Price Target: $15 → $16
Current: $3.38
Upside: +373.37%
May 19, 2025
Downgrades: Sector Perform
Price Target: $54 → $21
Current: $16.21
Upside: +29.55%
May 7, 2025
Maintains: Outperform
Price Target: $82 → $80
Current: $49.99
Upside: +60.03%
Mar 19, 2025
Reiterates: Outperform
Price Target: $8
Current: $1.47
Upside: +444.22%
Mar 19, 2025
Maintains: Buy
Price Target: $3
Current: $1.54
Upside: +94.81%
Jan 23, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $86.96
Upside: -19.50%
Jan 15, 2025
Reiterates: Outperform
Price Target: $18
Current: $4.71
Upside: +282.17%
Aug 6, 2024
Reiterates: Sector Perform
Price Target: $4
Current: $5.97
Upside: -33.00%